Categories AlphaGraphs, Earnings, Technology

Twitter revenue jumps in the first quarter, stocks rally

Microblogging site Twitter Inc. (TWTR) posted a 21% increase in total revenues to $665 million for the first quarter of 2018 compared to the prior year period.

GAAP net income was $61 million or $0.08 per share in Q1 2018, representing a net margin of 9%. This compares to a loss of $62 million or $0.09 per share for the first quarter of 2017. Adjusted net income was $123 million or $0.16 per share.

Twitter’s quarterly results beat market expectations, sending shares climbing as high as 13% following the earnings release.

Average monthly active users (MAU) increased 3% year over year to 336 million for the quarter while average daily active users (DAU) rose 10% year over year. The MAU metric reflects 69 million average monthly active users in the US and 267 million average international monthly active users.

Advertising revenue amounted to $575 million, an increase of 21% year over year. Owned and operated advertising revenue grew 28% year over year during Q1 2018, helped by audience growth and differentiated ad product features. Non-owned and operated advertising revenue fell 28% due to a decline from the deprecated TellApart product. Excluding this, non-owned and operating revenues would have increased 18%.

Twitter’s upbeat results sent shares climbing as high as 13% following the earnings release

Video now accounts for half of Twitter’s advertising revenues and was its fastest-growing ad format in Q1 2018. Data licensing and other revenue increased 20% year over year.

US revenues increased 2% to $347 million while international revenue grew 53% to $318 million year over year.

For the second quarter of 2018, the company expects adjusted EBITDA to be between $245 million and $265 million. For the full year of 2018, Twitter expects capital expenditures to come in between $375 million and $450 million.

Twitter Q1 2018 Earnings Infographic

 

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top